iBstone AuraLink vs Otofonix Encore

The iBstone AuraLink is a mid-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.6/5 in HearAdvisor's lab testing. This behind-the-ear device ranks #33 among 65 tested OTC hearing aids, placing it in the top 49% of its category. In our testing, the AuraLink shows a distinctive performance profile with notable strengths in audio entertainment. Music streaming scored a solid 3.6/5, measuring 1.68 points above the category average—a standout result for an OTC device. Feedback handling earned an excellent 5.0/5, sitting 0.46 points above average, meaning users should experience minimal whistling during daily wear. However, speech clarity presents a different picture. Speech in quiet scored a mixed 2.3/5, falling 0.47 points below the category average of 2.79. Speech in noise performance was low at 1.0/5, trailing the already modest category average by 0.48 points. Own-voice comfort scored 2.7/5, slightly above average but only mixed in absolute terms. At $649, the AuraLink faces competition from alternatives offering similar or better sound performance at lower prices, including the iHear MatriX and Olive Union Max. The AuraLink may appeal to users who prioritize music and media streaming over speech enhancement, but those seeking stronger speech clarity should explore other options in this price range.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.